Lasry Marc’s Rani Therapeutics RANI Stock Holding History

Lasry Marc’s Portfolio RANI Stock Details RANI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$31.4K	Hold	62,887	–	–	0.21%	9
2025 Q2	$32.3K	Hold	62,887	–	–	0.18%	7
2025 Q1	$79.2K	Hold	62,887	–	–	0.36%	8
2024 Q4	$86.2K	Hold	62,887	–	–	0.38%	10
2024 Q3	$136K	Hold	62,887	–	–	0.25%	9
2024 Q2	$239K	Hold	62,887	–	–	0.24%	10
2024 Q1	$196K	Hold	62,887	–	–	0.17%	10
2023 Q4	$209K	Hold	62,887	–	–	0.31%	9
2023 Q3	$137K	Hold	62,887	–	–	0.13%	12
2023 Q2	$259K	Hold	62,887	–	–	0.34%	12
2023 Q1	$324K	Hold	62,887	–	–	0.62%	9
2022 Q4	$602K	Hold	62,887	–	–	0.94%	9
2022 Q3	$602K	Buy	62,887 +59	+0.1%	+$625	1.16%	8
2022 Q2	$649K	Hold	62,828	–	–	0.99%	10
2022 Q1	$848K	Buy	+62,828	New	+$1.04M	0.42%	14

Other funds holding RANI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NFGH

Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

USAA

United Services Automobile Association San Antonio, Texas $1.24B AUM 2.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

KPWS

Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return

TPC

Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Lasry Marc's RANI Position: Q3 2025 in Review

Lasry Marc held its Rani Therapeutics (RANI) position steady in Q3 2025 at 62,887 shares worth $31.4K. The position accounts for 0.21% of the portfolio, ranked #9.

Lasry Marc first reported a position in RANI in Q1 2022 and has held it in 15 quarters since. The position peaked at $848K in Q1 2022. 38 funds tracked by Wall St. Rank hold RANI as of Q3 2025.

Lasry Marc held 62,887 shares of Rani Therapeutics worth $31.4K as of Q3 2025.
Lasry Marc left its Rani Therapeutics share count unchanged in Q3 2025.
Rani Therapeutics made up 0.21% of Lasry Marc's portfolio in Q3 2025, its #9 holding.
Lasry Marc first reported a position in Rani Therapeutics in Q1 2022 and has held it in 15 quarters since.
Lasry Marc's Rani Therapeutics position peaked at $848K in Q1 2022.
38 funds tracked by Wall St. Rank held Rani Therapeutics as of Q3 2025.

Based on Lasry Marc's 13F filing for Q3 2025, filed 14 Nov 2025.